HealthDay - THURSDAY, June 16 (HealthDay News) -- The introduction of a human papillomavirus (HPV) vaccination program in Australia led to a reduction in high-grade cervical abnormalities that are precursors to cervical cancer, a new study reports.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.